A-A-0051714 (DM)
9 October 1986
INTERIM COMMERCIAL ITEM DESCRIPTION
VITAMIN B COMPLEX AND ASCORBIC ACID TABLETS
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by DLA, Defense Personnel Support Center, Directorate of Medical Materiel, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient Characteristics:
Shall be Vitamin B Complex and Ascorbic Acid Tablets. Each tablet shall contain:
|
Folic Acid |
0 – 0.5 mg |
|
Vitamin B1 (Thiamine) |
15 – 25 mg |
|
Vitamin B2 (Riboflavin) |
10 -25 mg |
|
Vitamin B3 (Niacin) |
50 – 100 mg |
|
Vitamin B5 (Calcium Pantothenate) |
18 -23 mg |
|
Vitamin B6 (Pyridoxine Hydrochloride) |
4 – 10 mg |
|
Vitamin B12 (Cyanocobalamin) |
5 – 10 mg |
|
Vitamin C (Ascorbic Acid) |
300 – 500 mg |
Shall contain not less than 100 percent of the labeled amount of each ingredient listed above in each tablet. The tablet may contain excesses to maintain potency as allowed by the Food and Drug Administration (FDA).
Assay of the active ingredients in the finished tablet shall be determined by appropriate, accurate, and reproducible method(s). The bidder of offeror shall submit with its bid or proposal the detailed proposed method(s) of assay and identification. If the method(s) are approved and accepted by the Government, such methods shall be employed in the testing of tablets, and need not be resubmitted, provided the bidder or offeror certifies that there has been no change in formulation or method of manufacture.
Workmanship. Tablets shall be free from defects which may detract from its appearance or impair its serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business